Member Exclusive

Cell therapy weekly: First cell therapy from engineered pluripotent stem cell receives IND

This week: Orgenesis opens new offices to support point of care platform and AVROBIO, Inc. shares clinical data from phase I and II gene therapy trials.

Go to the profile of RegMedNet
Feb 07, 2019
0
0

Please sign in or register for FREE

No comments yet.